| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 医药商业(元) | 1,779,037,911.71 | 3,052,937,029.34 | 1,903,784,451.19 | 3,372,654,373.89 | 1,725,212,553.23 |
| 医药制造(元) | 2,003,344,291.27 | 4,291,459,855.29 | 2,195,653,726.98 | 4,724,203,786.96 | 2,707,986,318.47 |
| 其他(元) | 70,225,923.43 | - | 69,078,297.02 | 146,316,860.81 | 73,186,962.90 |
| 其他(含其他业务收入)(元) | - | 158,158,024.60 | - | - | - |
| 营业成本(元) | |||||
| 医药商业(元) | 1,659,497,112.68 | 2,817,026,196.35 | 1,787,722,221.49 | 3,084,808,590.28 | 1,570,543,976.99 |
| 医药制造(元) | 790,873,493.97 | 1,664,647,637.47 | 848,022,388.47 | 1,711,767,806.11 | 942,798,099.21 |
| 其他(元) | 64,798,780.10 | - | 55,316,101.24 | 93,619,191.51 | 57,074,337.21 |
| 其他(含其他业务收入)(元) | - | 114,792,445.70 | - | - | - |
| 毛利(元) | |||||
| 医药商业(元) | 119,540,799.03 | 235,910,832.99 | 116,062,229.70 | 287,845,783.61 | 154,668,576.24 |
| 医药制造(元) | 1,212,470,797.30 | 2,626,812,217.82 | 1,347,631,338.51 | 3,012,435,980.85 | 1,765,188,219.26 |
| 其他(元) | 5,427,143.33 | - | 13,762,195.78 | 52,697,669.30 | 16,112,625.69 |
| 其他(含其他业务收入)(元) | - | 43,365,578.90 | - | - | - |
| 毛利率(%) | |||||
| 医药商业(%) | 6.72 | 7.73 | 6.10 | 8.53 | 8.97 |
| 医药制造(%) | 60.52 | 61.21 | 61.38 | 63.77 | 65.18 |
| 其他(%) | 7.73 | - | 19.92 | 36.02 | 22.02 |
| 其他(含其他业务收入)(%) | - | 27.42 | - | - | - |
| 收入构成(%) | |||||
| 医药商业(%) | 46.18 | 40.69 | 45.67 | 40.91 | 38.28 |
| 医药制造(%) | 52.00 | 57.20 | 52.67 | 57.31 | 60.09 |
| 其他(%) | 1.82 | - | 1.66 | 1.78 | 1.62 |
| 其他(含其他业务收入)(%) | - | 2.11 | - | - | - |
| 毛利构成(%) | |||||
| 医药商业(%) | 8.94 | 8.12 | 7.86 | 8.58 | 7.99 |
| 医药制造(%) | 90.66 | 90.39 | 91.21 | 89.84 | 91.18 |
| 其他(%) | 0.41 | - | 0.93 | 1.57 | 0.83 |
| 其他(含其他业务收入)(%) | - | 1.49 | - | - | - |